A concise summary detailing what this focus area is, why it matters, and who it is designed to help.
Commercial & Industry Settings
Enable responsible, evidence-led decisions for food, supplement, and health innovation—linking product strategy to measurable outcomes and real-world performance.
Overview
Commercial settings shape diets at scale—through product design, formulation, labeling, and go-to-market decisions. We support responsible industry partners who want evidence that is credible, decision-ready, and aligned with real-world use. Our work spans innovation strategy, evidence planning, and real-world evaluation—helping teams de-risk choices, quantify expected impact, and communicate benefits responsibly within regulatory and scientific guardrails.
Solutions Used
A list of methods and capabilities utilized to execute the work and achieve the objectives within this focus area.
- Commercial Innovation (Foods & Supplements) — To guide evidence-led product and portfolio decisions, including opportunity assessment and evidence roadmapping.
- Evidence Synthesis & Guidelines — To assess the science behind ingredients, formulations, and dietary approaches and translate it into decision-ready conclusions.
- Claims Substantiation & Regulatory Strategy — To develop defensible claim strategies, documentation, and wording guardrails aligned with evidence and regulations.
- Real-World Evidence (RWE) Strategy & Post-Market Evaluation — To design real-world validation and monitoring plans that assess performance after launch.
- Data Science & Statistics — To quantify effects, assess heterogeneity, and produce transparent, reproducible analyses.
- Clinical, Data & AI Governance (Ethics, GDPR & Risk) — To ensure responsible governance when work involves health data, AI-enabled analytics, or human-subject evidence generation.
Key Measures
The specific clinical, economic, and programmatic indicators we track to quantify success and validate impact.
Depending on the question and setting, key measures may include:
- Benefit-aligned Endpoints: cardiometabolic, glycemic, inflammatory, satiety/appetite, or GI-related outcomes matched to intended benefit.
- Safety & Tolerability: adverse events, discontinuation, contraindication considerations (context-dependent).
- Exposure & Adherence: dose/formulation, compliance, real-world use patterns and persistence.
- Evidence Robustness: uncertainty, sensitivity analyses, consistency across evidence streams, and risk-of-bias considerations.
- Claim Readiness: strength-of-evidence framing, substantiation completeness, and alignment of wording with documented evidence.
- Real-world Performance: post-launch monitoring KPIs, subgroup response, and signals of benefit in intended user segments.
- Equity & Access: differential reach and outcomes across populations and settings (when relevant).
Related Focus Areas
Complementary health domains, populations, and settings that frequently intersect with this area of expertise.
